Reference
Sanchez-Herrero E, et al. NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment. Molecular Oncology 15: 2363-2376, No. 9, Sep 2021. Available from: URL: http://doi.org/10.1002/1878-0261.13033
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1888, 47 (2022). https://doi.org/10.1007/s40278-022-08389-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-08389-5